scispace - formally typeset
Y

Yong Beom Park

Researcher at Yonsei University

Publications -  362
Citations -  6643

Yong Beom Park is an academic researcher from Yonsei University. The author has contributed to research in topics: Medicine & Vasculitis. The author has an hindex of 36, co-authored 314 publications receiving 5426 citations.

Papers
More filters
Journal Article

Lipid profiles in untreated patients with rheumatoid arthritis.

TL;DR: The study suggests that patients with untreated active RA have altered lipoprotein and apolipoprotein patterns that may possibly expose them to higher risk of atherosclerosis.
Journal ArticleDOI

Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound.

TL;DR: The data indicate that rheumatoid arthritis patients have an ultrasonic marker of early atherosclerosis consistent with an increased risk for Atherosclerosis.
Journal Article

Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus

TL;DR: Serum levels ofIL-10 are elevated in SLE patients and increased IL-10 correlates well with SLE disease activity, and changes in serum IL- 10 levels also correlated with the changes in the SLEDAI score during the patients' disease course.
Journal ArticleDOI

Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification.

TL;DR: A low erythrocyte sedimentation rate at diagnosis and treatment with glucocorticoid were found to be independent predictors for remission, and the stable disease activity at diagnosis was an independent predictor for the quiescence of vascular lesions on follow‐up angiography.
Journal ArticleDOI

Targeted Chemo-Photothermal Treatments of Rheumatoid Arthritis Using Gold Half-Shell Multifunctional Nanoparticles

TL;DR: RGD-attached gold (Au) half-shell nanoparticles containing methotrexate (MTX) for the treatment of rheumatoid arthritis showed greater therapeutic effects than that of a conventional treatment with MTX solution in collagen-induced arthritic mice, and could be applied to other DMARDs for RA or other inflammatory diseases.